Investing.com - Novo Nordisk (CSE:NOVOb) ADR reported on Friday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Novo Nordisk ADR announced earnings per share of kr4.42 on revenue of kr30.93B. Analysts polled by Investing.com anticipated EPS of kr0.7 on revenue of kr4.86B.
Novo Nordisk ADR shares are up 14.6% from the beginning of the year and are trading at kr66.33 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Novo Nordisk ADR follows other major Healthcare sector earnings this month
Novo Nordisk ADR's report follows an earnings beat by J&J on October 13, who reported EPS of kr2.2 on revenue of kr21.08B, compared to forecasts EPS of kr1.98 on revenue of kr20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of kr0.72 on revenue of kr12.13B, compared to forecast for EPS of kr0.69 on revenue of kr12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar